Dr. Kruse-Jarres is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1959 NE Pacific St
Seattle, WA 98195Phone+1 206-292-6500Fax+1 206-689-8365
Education & Training
Tulane UniversityFellowship, Hematology and Medical Oncology, 2002 - 2005- Tulane UniversityResidency, Internal Medicine, 1999 - 2002
- Tulane University School of MedicineClass of 1999
Certifications & Licensure
MT State Medical License 2022 - 2026
ID State Medical License 2022 - 2025
WA State Medical License 2014 - 2025
AK State Medical License 2019 - 2024
LA State Medical License 2000 - 2018- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Clinical Trials
- Survey of Inhibitors in Plasma-Product Exposed Toddlers Start of enrollment: 2010 Jan 01
- Inhibitor Development in Patients With Hemophilia A Undergoing Surgery Start of enrollment: 2011 Nov 01
- Hemophilia Inhibitor Previously Untreated Patient Study Start of enrollment: 2011 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 436 citationsEmicizumab Prophylaxis in Patients Who Have Hemophilia A without InhibitorsJohnny Mahlangu, Johannes Oldenburg, Ido Paz-Priel, Claude Negrier, Markus Niggli
The New England Journal of Medicine. 2018-08-29 - 71 citationsUS Guidelines for immune tolerance induction in patients with haemophilia a and inhibitorsLeonard A. Valentino, Christine L. Kempton, Rebecca Kruse-Jarres, Prasad Mathew, Shannon L. Meeks
Haemophilia. 2015-09-01 - 245 citationsEmicizumab Prophylaxis in Hemophilia A with Inhibitors.Johannes Oldenburg, Johnny N Mahlangu, Benjamin Kim, Christophe Schmitt, Michael U Callaghan
The New England Journal of Medicine. 2017-08-31
Abstracts/Posters
- Patterns and Predictors of Emicizumab Adherence in People with HemophiliaRebecca Kruse-Jarres, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Quantitative Measurements of Hemophilic Joint Tissues By Point-of-Care Musculoskeletal Ultrasound Are Associated with Clinical and Functional Joint Outcome ParametersRebecca Kruse-Jarres, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Urinary Cross-Linked Carboxyterminal Telopeptide Decreases with Resolution of Painful Vaso-Occlusive Crises in Adults with Sickle Cell Disease - Results from the Sickl...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- What to Do When a Pre-Op Patient Has Abnormal Prothrombin Time (PT) or Partial Thromboplastin Time (PTT)60th American Society of Hematology Annual Meeting - 11/30/2018
Authored Content
- Emicizumab Prophylaxis in Hemophilia A with InhibitorsJuly 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
